RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of INO
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

High volatility in Inovio Pharmaceuticals stock price on Thursday which ended trading at $13.88
(Updated on Mar 28, 2024)

Buy or Hold candidate since Feb 16, 2024 Gain 75.03% PDF

The Inovio Pharmaceuticals stock price gained 6.52% on the last trading day (Thursday, 28th Mar 2024), rising from $13.03 to $13.88. During the last trading day the stock fluctuated 13.00% from a day low at $13.00 to a day high of $14.69. The price has risen in 6 of the last 10 days and is up by 28.4% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 602 thousand more shares were traded than the day before. In total, 894 thousand shares were bought and sold for approximately $12.41 million.

The stock lies in the upper part of a very wide and strong rising trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break-up at the top trend line at $14.82 will firstly indicate a stronger rate of rising. Given the current short-term trend, the stock is expected to rise 47.35% during the next 3 months and, with a 90% probability hold a price between $11.48 and $21.83 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

INO Signals & Forecast

The Inovio Pharmaceuticals stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $12.15 and $9.60. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Monday, February 05, 2024, and so far it has risen 183.27%. Further rise is indicated until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Inovio Pharmaceuticals stock

On the downside, the stock finds support just below today's level from accumulated volume at $12.04 and $11.25. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Inovio Pharmaceuticals finds support just below today's level at $12.04. If this is broken, then the next support from accumulated volume will be at $11.25 and $10.44.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $1.69 between high and low, or 13.00%. For the last week, the stock has had daily average volatility of 9.77%.

The Inovio Pharmaceuticals stock is overbought on RSI14 and lies in the upper part of the trend. Normally this may pose a good selling opportunity for the short-term trader, but some stocks may go long and hard while being overbought. Regardless, the high RSI together with the trend position increases the risk and higher daily movements (volatility) should be expected. A correction down in the nearby future seems very likely and it is of great importance that the stock manages to break the trend before that occurs.

Our recommended stop-loss: $13.41 (-3.42%) (This stock has high daily movements and this gives high risk. The RSI14 is 79 and this increases the risk substantially. There is a buy signal from a pivot bottom found 37 days ago.)

Trading Expectations (INO) For The Upcoming Trading Day Of Monday 1st

For the upcoming trading day on Monday, 1st we expect Inovio Pharmaceuticals to open at $13.86, and during the day (based on 14 day Average True Range), to move between $12.85 and $14.91, which gives a possible trading interval of +/-$1.03 (+/-7.44%) up or down from last closing price. If Inovio Pharmaceuticals takes out the full calculated possible swing range there will be an estimated 14.87% move between the lowest and the highest trading price during the day.

With no resistance above and support from accumulated volume @ $12.04, some $1.84 (13.26%) from the current price of $13.88, our system finds the risk reward attractive.

Is Inovio Pharmaceuticals stock A Buy?

Inovio Pharmaceuticals holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

Current score: 0.000 Hold/Accumulate Unchanged

Zero in score indicates that our system is expecting high volatility and risk for the following trading day. Given the latest developments, we cannot determine the next direction as it may go both ways.

Predicted Opening Price for Inovio Pharmaceuticals of Monday, April 1, 2024

Fair opening price April 1, 2024 Current price
$13.86 ( 0.168%) $13.88

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for INO

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 15.55 12.01 %
R2 14.90 7.36 %
R1 14.50 4.48 %
Current price: 13.88
Support S1 13.21 -4.82 %
S2 12.81 -7.69 %
S3 12.17 -12.34 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0 .
R2 0 .
R1 0 .
Current price 13.88
Support S1 12.04 -13.26%
S2 11.25 -18.95%
S3 10.44 -24.78%

INO Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 Sep 21, 2017 Sep 28, 2017 Oct 16, 2017 $0.0690 0.0926%
2 Aug 22, 2017 Aug 29, 2017 Sep 15, 2017 $0.0690 0.0963%
3 Jul 25, 2017 Jul 27, 2017 Aug 15, 2017 $0.0690 0.102%
4 Jun 23, 2017 Jun 28, 2017 Jul 17, 2017 $0.0690 0.0740%

FAQ

What is the symbol for Inovio Pharmaceuticals Stock and on which exchange is it traded?
The symbol for Inovio Pharmaceuticals is INO and it is traded on the NYSE (New York Stock Exchange).

Should I buy or sell Inovio Pharmaceuticals Stock?
Inovio Pharmaceuticals holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Inovio Pharmaceuticals Stock?
Inovio Pharmaceuticals Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Inovio Pharmaceuticals Stock.

What's the current price of Inovio Pharmaceuticals Stock?
As of the end of day on the 2024-03-28, the price of an Inovio Pharmaceuticals (INO) share was $13.88.

What is the 52-week high and low for Inovio Pharmaceuticals Stock?
The 52-week high for Inovio Pharmaceuticals Stock is $14.69 and the 52-week low is $3.84.

What is the market capitalization of Inovio Pharmaceuticals Stock?
As of the 2024-03-28, the market capitalization of Inovio Pharmaceuticals is 324.381M.

When is the next earnings date for Inovio Pharmaceuticals?
The upcoming earnings date for Inovio Pharmaceuticals is May 08, 2024.
Click to get the best stock tips daily for free!

About Inovio Pharmaceuticals

Inovio Pharmaceuticals Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA sequence of the target antigen, as well as CELLECTRA smart devices technology that facilitates delivery o... INO Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT